Mark Joing joined Menlo Therapeutics in February 2016 and is responsible for clinical trial execution and project management.  Mr. Joing brings 20+ years of drug development experience at large and small pharmaceutical companies to Menlo.  For five years prior to joining Menlo, Mr. Joing was VP of Clinical Operations and Project Management at Nora Therapeutics, a biotechnology company focused on developing therapeutics to address significant unmet needs in reproductive medicine.  As part of the senior management team at Nora, he led multiple Phase 1 and 2 clinical studies in the US and Europe.  Prior to Nora, Mr. Joing headed Clinical Operations and Project Management at Nuvelo, a late-stage drug development company.  He was the recipient of Nuvelo’s inaugural George Rathmann Award to recognize his significant contribution to Nuvelo’s mission of improving the lives of patients through the discovery, development and commercialization of novel acute cardiovascular and cancer therapies.  Earlier in his career, Mr Joing held roles in Supply Chain and Production Management at 3M Pharmaceuticals and Abbott Laboratories.

Mr. Joing holds a B.S. in chemical engineering from Northwestern University and M.B.A. from Stanford University.